Stocktoria
Larimar Therapeutics, Inc. LRMR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-06-19
Larimar Therapeutics, Inc. statistics & valuation
Market cap$380.2M
P / B4.9×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -113.6% | -40.3% | -38.5% | -28.0% | -64.4% |
| Return on equity | -212.2% | -46.9% | -45.2% | -31.9% | -78.6% |
| Current ratio | 2.19 | 8.02 | 9.49 | 11.28 | 8.16 |
Source: SEC EDGAR filings · CIK 0001374690 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.